MannKind Corp.

$4.21 0.00% ($0.00)

Get ready to invest

Join the waitlist

About MannKind Corp.

MannKind Corporation is a biopharmaceutical company. The Company is focused on the development and commercialization of inhaled therapeutic products for diabetes and orphan lung diseases, such as pulmonary arterial hypertension. The Company's product candidate is Afrezza (insulin human) Inhalation Powder, which is an inhaled insulin used to control high blood sugar in adults with type I and type II diabetes and also to improve glycemic control. AFREZZA consists of a dry formulation of human insulin delivered from a small and portable inhaler. AFREZZA utilizes its technosphere formulation technology. The technosphere is a drug delivery platform that may allow the oral inhalation of a range of therapeutics.

Popular Stocks	Price	Change
Palantir Technologies PLTR	$25.42 8.23%	8.23%
Nio NIO	$38.48 4.96%	4.96%
Apple AAPL	$134.43 1.01%	1.01%
Grupo Televisa TV	$10.12 3.66%	3.66%
Wells Fargo WFC	$39.79 5.94%	5.94%
Amc Entertainment AMC	$8.84 1.22%	1.22%
General Electric GE	$13.44 1.11%	1.11%
R Riot Blockchain RIOT	$59.26 15.89%	15.89%
Tesla Motors TSLA	$762.32 3.68%	3.68%
C Coinbase Global Inc COIN	$250 17.94%	17.94%